
Results
5
High Growth Stocks
5 companies
Zevra Therapeutics
Market Cap: US$672.2m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$11.53
7D
0.4%
1Y
25.3%
Eton Pharmaceuticals
Market Cap: US$1.7b
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$58.86
7D
34.8%
1Y
259.6%
Kiniksa Pharmaceuticals International
Market Cap: US$6.0b
A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
KNSA
US$79.18
7D
3.5%
1Y
134.8%
Arcutis Biotherapeutics
Market Cap: US$3.3b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$25.61
7D
-1.2%
1Y
53.0%
Sotera Health
Market Cap: US$5.4b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$18.80
7D
-0.9%
1Y
19.0%